Conmed (CNMD) Other Non-Current Liabilities (2010 - 2026)

Conmed (CNMD) has reported Other Non-Current Liabilities for 17 consecutive years, with $61.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Non-Current Liabilities fell 22.47% year-over-year to $61.9 million; the trailing twelve-month figure through Jun 2026 stood at $61.9 million (down 22.47% YoY), and the FY2025 full-year result was $63.9 million, down 26.01% from the prior year.
• Other Non-Current Liabilities retreated to $61.9 million in Q2 2026 per CNMD's latest filing, from $63.0 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $218.1 million in Q3 2022 and bottomed at $41.8 million in Q1 2022.
• Historically, Other Non-Current Liabilities has averaged $110.5 million across 5 years, with a median of $100.9 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Other Non-Current Liabilities soared 373.8% in 2022, then sank 41.41% in 2024.
• Over 5 years, Other Non-Current Liabilities stood at $203.7 million in 2022, then sank by 40.58% to $121.0 million in 2023, then retreated by 28.7% to $86.3 million in 2024, then declined by 26.01% to $63.9 million in 2025, then declined by 3.08% to $61.9 million in 2026.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $61.9 million, $63.0 million, and $63.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.